186 results
8-K
EX-10.2
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
.
Restrictive Covenants. The Executive acknowledges and agrees that during the term of Executive’s employment because of the nature of the Executive’s
8-K
EX-10.1
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
and agrees that during the term of Executive’s employment because of the nature of the Executive’s responsibilities and the resources provided by the Company
8-K
EX-10.1
s11hi
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
8-K
EX-10.1
9v0pmqxzf
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
D
zq1rixxp
28 Oct 22
$5.00 mm in debt / securities to be acquired, sold $317.50 k, 2 investors
1:29pm